Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate

Background: Estimation is a widely used method of assessing the weight of patients with acute stroke. Because the dosage of tissue plasminogen activator (tPA) is weight-dependent, errors in estimation lead to incorrect dosing. Methods: We installed a ground-level scale in the computed tomography (CT...

Full description

Bibliographic Details
Main Authors: Andreas Ragoschke-Schumm, Asem Razouk, Martin Lesmeister, Stefan Helwig, Iris Q. Grunwald, Klaus Fassbender
Format: Article
Language:English
Published: Karger Publishers 2017-05-01
Series:Cerebrovascular Diseases Extra
Subjects:
Online Access:http://www.karger.com/Article/FullText/474955
id doaj-4a3ec021dc5643a190ce2b6bd91c0fc8
record_format Article
spelling doaj-4a3ec021dc5643a190ce2b6bd91c0fc82020-11-25T03:41:36ZengKarger PublishersCerebrovascular Diseases Extra1664-54562017-05-017210311010.1159/000474955474955Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to EstimateAndreas Ragoschke-SchummAsem RazoukMartin LesmeisterStefan HelwigIris Q. GrunwaldKlaus FassbenderBackground: Estimation is a widely used method of assessing the weight of patients with acute stroke. Because the dosage of tissue plasminogen activator (tPA) is weight-dependent, errors in estimation lead to incorrect dosing. Methods: We installed a ground-level scale in the computed tomography (CT) suite of our hospital and also integrated a scale into the CT table of our Mobile Stroke Unit in order to prospectively assess the differences between reported, estimated, and measured weights of acute stroke patients. An independent rater asked patients to report their weight. The patients’ weights were also estimated by the treating physician and measured with a scale. Differences between reported, estimated, and measured weights were analyzed statistically. Results: For 100 consecutive patients, weighing was possible without treatment delays. Weights estimated by the physician diverged from measured weights by 10% or more for 27 patients and by 20% or more for 6 patients. Weights reported by the patient diverged from measured weights by 10% or more for 12 patients. Weights reported by the patients differed significantly less from measured weights (mean, 4.1 ± 3.1 kg) than did weights estimated by the physician (5.7 ± 4.4 kg; p = 0.003). Conclusion: This first prospective study of weight assessment in acute stroke shows that the use of an easily accessible scale makes it feasible to weigh patients with acute stroke without the treatment delay associated with additional patient transfers. Physicians’ estimates of patients’ weights demonstrated substantial aberrations from measured weights. Avoiding these deviations would improve the accuracy of tPA dosage.http://www.karger.com/Article/FullText/474955Stroke teamsAcute stroke treatmentIschemic strokeClinical trialTissue plasminogen activatorThrombolysisWeight
collection DOAJ
language English
format Article
sources DOAJ
author Andreas Ragoschke-Schumm
Asem Razouk
Martin Lesmeister
Stefan Helwig
Iris Q. Grunwald
Klaus Fassbender
spellingShingle Andreas Ragoschke-Schumm
Asem Razouk
Martin Lesmeister
Stefan Helwig
Iris Q. Grunwald
Klaus Fassbender
Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
Cerebrovascular Diseases Extra
Stroke teams
Acute stroke treatment
Ischemic stroke
Clinical trial
Tissue plasminogen activator
Thrombolysis
Weight
author_facet Andreas Ragoschke-Schumm
Asem Razouk
Martin Lesmeister
Stefan Helwig
Iris Q. Grunwald
Klaus Fassbender
author_sort Andreas Ragoschke-Schumm
title Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
title_short Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
title_full Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
title_fullStr Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
title_full_unstemmed Dosage Calculation for Intravenous Thrombolysis of Ischemic Stroke: To Weigh or to Estimate
title_sort dosage calculation for intravenous thrombolysis of ischemic stroke: to weigh or to estimate
publisher Karger Publishers
series Cerebrovascular Diseases Extra
issn 1664-5456
publishDate 2017-05-01
description Background: Estimation is a widely used method of assessing the weight of patients with acute stroke. Because the dosage of tissue plasminogen activator (tPA) is weight-dependent, errors in estimation lead to incorrect dosing. Methods: We installed a ground-level scale in the computed tomography (CT) suite of our hospital and also integrated a scale into the CT table of our Mobile Stroke Unit in order to prospectively assess the differences between reported, estimated, and measured weights of acute stroke patients. An independent rater asked patients to report their weight. The patients’ weights were also estimated by the treating physician and measured with a scale. Differences between reported, estimated, and measured weights were analyzed statistically. Results: For 100 consecutive patients, weighing was possible without treatment delays. Weights estimated by the physician diverged from measured weights by 10% or more for 27 patients and by 20% or more for 6 patients. Weights reported by the patient diverged from measured weights by 10% or more for 12 patients. Weights reported by the patients differed significantly less from measured weights (mean, 4.1 ± 3.1 kg) than did weights estimated by the physician (5.7 ± 4.4 kg; p = 0.003). Conclusion: This first prospective study of weight assessment in acute stroke shows that the use of an easily accessible scale makes it feasible to weigh patients with acute stroke without the treatment delay associated with additional patient transfers. Physicians’ estimates of patients’ weights demonstrated substantial aberrations from measured weights. Avoiding these deviations would improve the accuracy of tPA dosage.
topic Stroke teams
Acute stroke treatment
Ischemic stroke
Clinical trial
Tissue plasminogen activator
Thrombolysis
Weight
url http://www.karger.com/Article/FullText/474955
work_keys_str_mv AT andreasragoschkeschumm dosagecalculationforintravenousthrombolysisofischemicstroketoweighortoestimate
AT asemrazouk dosagecalculationforintravenousthrombolysisofischemicstroketoweighortoestimate
AT martinlesmeister dosagecalculationforintravenousthrombolysisofischemicstroketoweighortoestimate
AT stefanhelwig dosagecalculationforintravenousthrombolysisofischemicstroketoweighortoestimate
AT irisqgrunwald dosagecalculationforintravenousthrombolysisofischemicstroketoweighortoestimate
AT klausfassbender dosagecalculationforintravenousthrombolysisofischemicstroketoweighortoestimate
_version_ 1724529283894870016